Skip to main content
OpenTrials
Completed

NCT Number: NCT01364948

Effect of Coconut Oil Application in Reducing Water Loss From Skin of Premature Babies in First Week of Life (TEWL)

The skin of newborn infants is immature and ineffective as a barrier. Preterm skin exhibits even more vulnerability to the environment due to poor self regulatory heat mechanisms, paucity of fatty tissue and its thinness. Most preterm babies lose up to 13% of their weight as water loss from their skin during the first week of life. Many strategies have been utilized by neonatologists to decrease this water loss. Oil application on the skin can act as a non permeable barrier and can help in reducing water loss from the skin. Edible coconut oil, often used for traditional massage of babies by Indian communities, is culturally acceptable and Hence the investigators decided to undertake this study to objectively assess the reduction in water loss from skin after oil application

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 hour–168 hour

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

All India Institute Of Medical Sciences

New Delhi, National Capital Territory of Delhi, 110029, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All preterm babies born at the study center with birth weight < 1500gms were eligible for inclusion in the study.

Exclusion criteria

  • Babies with birth weight less than 750 gms at birth
  • Babies with major congenital malformations.
  • Babies with severe asphyxia, hydrops and shock.
  • Babies with congenital diseases of skin associated with skin breach or denudation of skin precluding oil application
  • Babies with preexisting skin infection such as multiple furuncles (2 or more skin areas - each limb, head, chest, abdomen and back are the individual areas that will be taken as one area

Treatment and study plan

Coconut oil application

Other

Four ml coconut oil application twice daily for first week

No oil application

Other

Oil application was not done

Primary outcomes

  1. Trans Epidermal Water Loss(TEWL)

    Time frame: first 7 days of life

    TEWL was measured using evaporimeter(Vapometer, Delfin Technologies limited, Kuopio, Finland) at 12 hours of age and thereafter every 12 hours during the first week of life (168 hrs of life)

Secondary outcomes

  1. Weight

    Time frame: Weight first 7 days of life and 40 weeks postmenstrual age

    The weight of the neonate was recorded at birth and daily during the first week of life. The weight in grams and weight gain in grams/kilogram/day was measured at 40 weeks post conceptional age.

  2. Skin condition Score

    Time frame: Skin condition Score at day 7 of life

    Skin Condition Score was measured using 'Lane and Drost' Score.This score has 9 scores from 1 to 9, 1 depicting the best skin state and 9 the worst with erythema, blistering & oozing over the entire area.

  3. Skin colonization pattern

    Time frame: Skin colonization pattern at day 7 of life

    The skin swab cultures were sent after 1week of life to assess for skin colonization

Sponsors and collaborators

Lead sponsor

All India Institute of Medical Sciences

Other

Registry information

Official study title

Effect of Topical Oil Application on Trans-epidermal Water Loss (TEWL) in Preterm Very Low Birth Weight (VLBW) Infants - A Randomized Clinical Trial

Acronym: TopOilTewl

Important dates

Study start
2006
Primary completion
2006
Study completion
2006
First posted
Jun 3, 2011
Registry last updated
Jun 3, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.